Radboud University in the Netherlands is offering a fully funded PhD position in Molecular Biology, focusing on the study of protein regulatory networks in cancer within the Vermeulen Lab. The project is part of the Oncode Accelerator Growth Fund and aims to accelerate the development of new cancer therapies by employing innovative omics strategies and proteomic tools to study protein interactions and signaling pathways in primary cancer tissues, organoids, and clinical samples. The research will involve optimizing and implementing proteomic workflows for highly limited, heterogeneous samples, enabling in-depth profiling of tumor biology. A significant component includes establishing intratumoral heterogeneity maps using spatial proteomic profiling and exploring single-cell proteomics approaches to gain additional resolution on cell-state diversity within tumors. Collaboration with a postdoctoral researcher will facilitate the development and application of novel proximity-labeling strategies to chart dynamic protein–protein interactions and local proteome environments. These efforts will contribute to large-scale interaction and signaling network analyses across clinically annotated cohorts, generating a high-resolution view of cancer-specific protein interaction networks and informing new hypotheses on epigenetic control in cancer. The Vermeulen Lab specializes in state-of-the-art proteomics technologies to understand how proteins and protein networks regulate gene expression and cell fate in health and disease. The group is dynamic, internationally recognized, and part of the Oncode Accelerator consortium, offering opportunities for collaboration with affiliated groups and pharmaceutical companies across the Netherlands. The Faculty of Science at Radboud University is known for its groundbreaking research, excellent education, and strong international character, providing a supportive and inclusive environment for researchers from over 70 countries. Applicants must have a Master’s degree in Molecular Biology, Biochemistry, Biomedical Sciences, or a related field, with a strong interest in mass spectrometry-based proteomics, cancer biology, and gene regulation. Hands-on experience with mammalian cell culture and molecular cloning is required, and prior experience with mass spectrometry-based techniques is advantageous. Candidates should possess a collaborative mindset, analytical thinking skills, and motivation to work in an interdisciplinary environment. The position offers a temporary employment contract (1.0 FTE) of 1.5 years, extendable by 2.5 years upon positive evaluation. The starting gross monthly salary is €3,059, increasing to €3,881 in the fourth year, with additional benefits such as an 8% holiday allowance, 8.3% end-of-year bonus, extra days off, flexible working hours, a good pension plan, and discounts on sports and cultural activities. Dual Career Coaching may be available for partners. The application deadline is 04 January 2026. Interested candidates should apply online via the Radboud University job portal, addressing their application letter to Professor Michiel Vermeulen and submitting all required documents as specified in the application form. This is an excellent opportunity for candidates passionate about molecular biology, proteomics, and cancer research to join a leading research group and contribute to impactful scientific discoveries.

Radboud University is offering a fully funded PhD position in Molecular Biology, focusing on proteomics and cancer research within the renowned Vermeulen Lab at the Faculty of Science. This project is part of the Oncode Accelerator Growth Fund initiative, aiming to accelerate the development of new cancer therapies by investigating protein regulatory networks and their role in oncogenic signalling and disease progression. As a PhD candidate, you will develop and apply innovative omics strategies to study protein–protein interactions and dynamic protein states, which are crucial for cellular identity and tumour biology. The research will employ advanced proteomic tools and workflows, including mass spectrometry, spatial proteomic profiling, and single-cell proteomics, to analyze primary cancer tissues, organoids, and clinical samples. A significant aspect of the project involves optimizing proteomic workflows for highly limited and heterogeneous samples, enabling in-depth profiling of tumour biology and establishing intratumoral heterogeneity maps using laser capture microdissection. You will collaborate closely with a postdoctoral researcher to develop and implement novel proximity-labelling strategies, charting dynamic protein–protein interactions and local proteome environments. These methodological advancements will contribute to large-scale interaction and signalling network analyses across clinically annotated cohorts, providing unprecedented insights into how cancer-specific protein interaction networks are rewired in human disease. The findings are expected to inform new hypotheses on epigenetic control in cancer and support the translational goals of identifying actionable molecular targets for drug development. The Vermeulen Lab is internationally recognized for its expertise in state-of-the-art proteomics technologies and offers a dynamic, interdisciplinary research environment. As part of the Oncode Accelerator consortium, you will collaborate with affiliated groups across the Netherlands and have access to clinical material and expertise in translational cancer research, as well as opportunities to connect with pharmaceutical companies. Employment conditions include a temporary contract (1.0 FTE) for 1.5 years, extendable by 2.5 years upon positive evaluation. The starting salary is €3,059 gross per month, increasing to €3,881 in the fourth year, with additional benefits such as an 8% holiday allowance, 8.3% end-of-year bonus, extra annual leave (30 or 41 days), pension plan, and discounts on sports and cultural activities. Radboud University provides a supportive and inclusive work environment, with flexible working hours, training and development opportunities, and dual career coaching for partners. Applicants must hold a Master’s degree in Molecular Biology, Biochemistry, Biomedical Sciences, or a related field, with a strong interest in mass spectrometry-based proteomics, cancer biology, and gene regulation. Hands-on experience with mammalian cell culture and molecular cloning is required, and prior experience with mass spectrometry-based techniques is advantageous. Candidates should possess analytical thinking skills, a collaborative mindset, and motivation to work in an interdisciplinary setting. To apply, submit your application via the provided online link, addressing your letter to Prof. Michiel Vermeulen. Ensure all required documents are included as specified in the application form. The application deadline is 4 January 2026, with interviews scheduled to begin on 23 January. For further information, contact Prof. Michiel Vermeulen at [email protected].

Radboud University’s Vermeulen Lab is offering a fully funded PhD position focused on the study of protein regulatory networks in cancer. This project is part of the Oncode Accelerator Growth Fund, aiming to accelerate the development of new cancer therapies by leveraging innovative omics strategies. As a PhD candidate, you will develop and apply advanced proteomic tools to investigate protein interactions and signalling pathways in primary cancer tissues, organoids, and clinical samples. The research will connect molecular mechanisms to tumour biology, with the goal of identifying novel actionable targets for drug development. You will work extensively with patient-derived FFPE material, optimizing proteomic workflows for highly limited and heterogeneous samples to enable in-depth profiling of tumour biology. A major aspect of the project involves establishing intratumoral heterogeneity maps using spatial proteomic profiling, including laser capture microdissection and mass spectrometry analysis. Where feasible, you will also explore single-cell proteomics approaches to gain additional resolution on cell-state diversity within tumours. Collaboration is a key component, as you will work closely with a postdoctoral researcher to develop and apply novel proximity-labelling strategies for charting dynamic protein–protein interactions and local proteome environments. These methodological advances will contribute to large-scale interaction and signalling network analyses across clinically annotated cohorts, generating a high-resolution view of cancer-specific protein interaction networks. The findings are expected to inform new hypotheses on epigenetic control in cancer and support Oncode Accelerator’s translational goals. The Vermeulen Lab specializes in state-of-the-art proteomics technologies to understand how proteins and protein networks regulate gene expression and cell fate in health and disease. You will join a dynamic, internationally recognized research group with access to clinical material and expertise in translational cancer research, as well as opportunities to collaborate with pharmaceutical companies. Radboud University’s Faculty of Science is committed to groundbreaking research and excellent education, fostering an inclusive and international environment. The university offers a competitive employment package, including a starting salary of €3,059 gross per month (increasing to €3,881 in the fourth year), 8% holiday allowance, 8.3% end-of-year bonus, extra annual leave, flexible working hours, and a good pension plan. Dual Career Coaching is available for partners, and employees receive discounts on sports and cultural activities. Applicants should hold a Master’s degree in Molecular Biology, Biochemistry, Biomedical Sciences, or a related field, with a strong interest in mass spectrometry-based proteomics, cancer biology, and gene regulation. Hands-on experience with mammalian cell culture and molecular cloning is required; prior experience with mass spectrometry-based techniques is advantageous. Candidates should be collaborative, analytical, and motivated to work in an interdisciplinary setting. The application deadline is 4 January 2026. Interviews will begin on 23 January, with a possible second round on 12 February. For more information, contact Prof. Michiel Vermeulen at [email protected]. Apply online via the provided link, addressing your application letter to Prof. Vermeulen and including the required documents as specified in the application form.

Radboud University is offering a fully funded PhD position in Molecular Biology at the Vermeulen Lab, Faculty of Science, in the Netherlands. The research focuses on protein regulatory networks in cancer, proteomics-driven discovery of protein–protein interactions, spatial proteomics on FFPE tumour samples, mapping intratumoral heterogeneity, single-cell proteomics, and identifying novel drug targets. The project is part of the Oncode Accelerator Growth Fund, aiming to accelerate new cancer therapies through innovative omics strategies. As a PhD candidate, you will develop and optimize proteomic workflows for limited clinical samples, perform proteomics on primary tissues, organoids, and patient-derived FFPE samples, and establish tumour heterogeneity maps using spatial proteomics. You will also apply single-cell proteomics and collaborate on proximity-labelling tool development, conducting large-scale signalling network analyses in annotated cancer cohorts. Up to 10% of your time may involve teaching responsibilities. Eligibility requires a Master’s degree in Molecular Biology, Biochemistry, Biomedical Sciences, or a related field, with strong interest in proteomics, cancer biology, and gene regulation. Experience with mammalian cell culture and molecular cloning is essential, and prior mass spectrometry experience is advantageous. The ideal candidate will have a collaborative mindset, analytical skills, and motivation for interdisciplinary research. The position offers a gross monthly salary of €3,059–€3,881, an 8% holiday allowance, and an 8.3% end-of-year bonus. The initial contract is for 1.5 years, extendable by 2.5 years upon positive evaluation. Additional benefits include extra annual leave, flexible working hours, sports and cultural discounts, pension plan, and professional development opportunities. The Vermeulen Lab is internationally recognized for its expertise in interaction proteomics and translational cancer research, providing access to clinical material and pharmaceutical collaborations. Applications must be submitted online via the Radboud University job portal, addressed to Professor Michiel Vermeulen. The deadline is 04 January 2026, with interviews scheduled for January and February. For more information, visit the provided links or contact the lab through the university website.

Radboud University is offering a fully funded PhD position in Molecular Biology, focusing on the study of protein regulatory networks in cancer within the Vermeulen Lab. The research aims to develop and apply innovative omics strategies to understand how protein–protein interactions and dynamic protein states influence cellular identity and drive oncogenic signaling and disease progression. The project is part of the Oncode Accelerator Growth Fund, targeting the acceleration of new cancer therapies. As a PhD candidate, you will employ and develop proteomic tools to study protein interactions and signaling pathways in primary cancer tissues, organoids, and clinical samples. The work includes optimizing proteomic workflows for limited and heterogeneous samples, establishing intratumoral heterogeneity maps using spatial proteomic profiling, and exploring single-cell proteomics approaches. Collaboration with a postdoctoral researcher will enable the development of novel proximity-labelling strategies to chart dynamic protein–protein interactions. These efforts will contribute to large-scale network analyses across clinically annotated cohorts, aiming to identify actionable molecular targets for drug development. The Vermeulen Lab is internationally recognized for its expertise in state-of-the-art proteomics technologies and translational cancer research. The group collaborates with affiliated groups across the Netherlands and has access to clinical material and pharmaceutical industry connections. The Faculty of Science at Radboud University is known for its groundbreaking research and international environment, offering excellent support for personal and professional development. Applicants should have a Master’s degree in Molecular Biology, Biochemistry, Biomedical Sciences, or a related field, with strong interest and experience in mass spectrometry-based proteomics, cancer biology, and gene regulation. Hands-on experience with mammalian cell culture and molecular cloning is required; prior experience with mass spectrometry is advantageous. The position requires a collaborative mindset, analytical skills, and motivation for interdisciplinary work. The PhD position is a full-time, four-year contract (initially 1.5 years, extendable by 2.5 years upon positive evaluation), with a starting salary of €3,059 per month, rising to €3,881 in the fourth year. Benefits include an 8% holiday allowance, 8.3% end-of-year bonus, extra annual leave, flexible working hours, pension plan, and discounts on sports and cultural activities. Dual Career Coaching is available for partners. The application deadline is 4 January 2026. For more information and to apply, visit the Radboud University job portal.

Radboud University in the Netherlands is offering a PhD position in Molecular Biology, focusing on advanced molecular techniques and cutting-edge biomedical research in cancer proteomics. The successful candidate will join the Vermeulen Lab, a dynamic and internationally recognized research group specializing in state-of-the-art proteomics technologies to study protein regulatory networks in cancer. The project is part of the Oncode Accelerator Growth Fund and aims to accelerate the development of new cancer therapies by investigating protein–protein interactions and dynamic protein states in primary cancer tissues, organoids, and clinical samples. Key research activities include optimizing proteomic workflows for heterogeneous samples, establishing intratumoral heterogeneity maps using spatial proteomic profiling, and exploring single-cell proteomics approaches. The candidate will collaborate closely with a postdoctoral researcher to develop proximity-labelling strategies for charting dynamic protein–protein interactions. The findings are expected to inform new hypotheses on epigenetic control in cancer and contribute to translational goals of identifying actionable molecular targets for drug development. Applicants must hold a Master’s degree in Molecular Biology, Biochemistry, Biomedical Sciences, or a related field, with strong interest and experience in mass spectrometry-based proteomics, cancer biology, and gene regulation. Hands-on experience with mammalian cell culture and molecular cloning is required; prior experience with mass spectrometry-based techniques is advantageous. The position offers a competitive salary starting at €3,059 per month, increasing to €3,881 in the fourth year, plus holiday and end-of-year bonuses, flexible working hours, extra annual leave, sports/cultural discounts, pension plan, and training opportunities. Dual Career Coaching may be available for partners. The application deadline is 04 January 2026. Candidates should apply online via the Radboud University job portal, addressing their application to Professor Michiel Vermeulen and including all required documents. Interviews will be held in January and February 2026. This opportunity provides excellent training in a collaborative, international environment with strong research exposure and access to clinical material and pharmaceutical industry connections.

Radboud University in the Netherlands is seeking a Molecular Biology Analyst to join the Radboud Institute for Molecular Life Sciences (RIMLS-Science) within the Faculty of Science. This position is part of the Oncode Accelerator project, which aims to accelerate the development of new cancer treatments. The successful candidate will work in the lab of Prof. Dr. Michiel Vermeulen, focusing on proteomics analyses to identify cellular targets and off-targets of novel cancer drugs and lead compounds. The role involves hands-on laboratory work, including the operation and maintenance of advanced mass spectrometry equipment for proteomics experiments. The analyst will also contribute to general lab management, such as overseeing laboratory use, ordering supplies, and ensuring safety protocols. Collaboration with other researchers, students, and groups within the Oncode Accelerator project is a key aspect of the position, as is maintaining contacts with colleagues from other departments and external suppliers. Applicants must have a completed HLO degree in Biology (BML), Biochemistry, or a related field, and possess experience with various molecular biology techniques. Strong laboratory skills, motivation for both fundamental and applied research, and good communication abilities are essential. Proficiency in English (written and spoken) is required due to the international nature of the lab environment. The position offers a one-year contract (0.8–1.0 FTE) with a gross monthly salary ranging from €3,057 to €3,985, depending on qualifications and experience. Additional benefits include 8% holiday allowance, 8.3% year-end bonus, extra vacation days (30 or 41 for full-time), flexible working hours, options for remote work, sports and culture discounts, and a comprehensive pension scheme. Radboud University provides a supportive, collegial, and inclusive work environment with opportunities for professional development and work-life balance. The central research themes at RIMLS-Science include gene expression regulation, genomics, and epigenomics, with a focus on understanding genetic and epigenetic mechanisms underlying development and disease, particularly cancer and infectious diseases. The department is equipped with state-of-the-art facilities for next-generation sequencing and quantitative mass spectrometry. To apply, candidates should submit their application via the Radboud University job portal, addressing their letter to Prof. Dr. Michiel Vermeulen, and include all required documents as specified in the application form. The application deadline is March 8, 2026. For more information, applicants can visit the university's website or contact Prof. Vermeulen directly.